Naz Rahman
Stock Analyst at Maxim Group
(0.29)
# 4,113
Out of 4,847 analysts
37
Total ratings
16.13%
Success rate
-42.27%
Average return
Main Sectors:
Stocks Rated by Naz Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLMD Galmed Pharmaceuticals | Downgrades: Hold | n/a | $1.48 | - | 1 | Apr 4, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $17 | $8.72 | +94.95% | 1 | Apr 2, 2025 | |
| SLXN Silexion Therapeutics | Maintains: Buy | $9 → $5 | $0.95 | +426.04% | 2 | Mar 20, 2025 | |
| SCPH scPharmaceuticals | Maintains: Buy | $20 → $12 | $3.87 | +210.08% | 3 | Mar 20, 2025 | |
| VKTX Viking Therapeutics | Maintains: Buy | $120 → $70 | $26.61 | +163.06% | 5 | Feb 7, 2025 | |
| NRSN NeuroSense Therapeutics | Downgrades: Hold | n/a | $1.74 | - | 2 | Dec 16, 2024 | |
| CING Cingulate | Upgrades: Buy | n/a | $4.02 | - | 4 | Nov 20, 2024 | |
| PALI Palisade Bio | Maintains: Buy | $23 → $8 | $0.74 | +986.96% | 7 | Nov 13, 2024 | |
| PRFX PainReform | Downgrades: Hold | n/a | $2.02 | - | 2 | Oct 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $3 | $0.67 | +347.69% | 1 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $140 | $8.97 | +1,460.76% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $446.48 | - | 1 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.29 | - | 3 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.55 | +222.58% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.04 | - | 1 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $2.27 | +164.32% | 1 | Feb 25, 2022 |
Galmed Pharmaceuticals
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.48
Upside: -
Nuvectis Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $17
Current: $8.72
Upside: +94.95%
Silexion Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $9 → $5
Current: $0.95
Upside: +426.04%
scPharmaceuticals
Mar 20, 2025
Maintains: Buy
Price Target: $20 → $12
Current: $3.87
Upside: +210.08%
Viking Therapeutics
Feb 7, 2025
Maintains: Buy
Price Target: $120 → $70
Current: $26.61
Upside: +163.06%
NeuroSense Therapeutics
Dec 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.74
Upside: -
Cingulate
Nov 20, 2024
Upgrades: Buy
Price Target: n/a
Current: $4.02
Upside: -
Palisade Bio
Nov 13, 2024
Maintains: Buy
Price Target: $23 → $8
Current: $0.74
Upside: +986.96%
PainReform
Oct 24, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.02
Upside: -
Assertio Holdings
Jul 26, 2024
Initiates: Buy
Price Target: $3
Current: $0.67
Upside: +347.69%
Mar 15, 2024
Maintains: Buy
Price Target: $525 → $140
Current: $8.97
Upside: +1,460.76%
Jan 31, 2024
Downgrades: Hold
Price Target: n/a
Current: $446.48
Upside: -
Nov 17, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.29
Upside: -
Aug 9, 2023
Initiates: Buy
Price Target: $5
Current: $1.55
Upside: +222.58%
May 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.04
Upside: -
Feb 25, 2022
Initiates: Buy
Price Target: $6
Current: $2.27
Upside: +164.32%